Nektar Therapeutics

NASDAQ:NKTR

Biotechnology

Healthcare
$32.54 -2.04%

-$1.24 today

Market cap
$933.51M
Beta
1.15
P/E (TTM)
-9.3
EPS (TTM)
-$6.39
52W Low $8.27High $109.00

Volume 0.86M

Average 1.00M

Balance Sheet

Inspect the capital base behind the business.

Assets

$280.41M

FY 2025 · Annual

-7.7% YoY

Liabilities

$190.57M

FY 2025 · Annual

-21.6% YoY

Equity

$89.83M

FY 2025 · Annual

+47.9% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents25.22M88.23M35.28M44.25M15.12M
Short-term Investments708.74M416.75M268.34M210.97M230.64M
Net Receivables22.49M8.4M2.25M1.61M1.78M
Inventory15.8M19.2M16.1M00
Other Current Assets00000
Total Current Assets795.58M545.97M330.7M261.29M266.27M
Property, Plant & Equipment (Net)177.54M85.89M36.86M11.82M5M
Goodwill76.5M76.5M000
Intangible Assets00000
Long-term Investments64.83M025.83M26.09M3.49M
Tax Assets00000
Other Non-current Assets2.74M2.25M4.64M4.65M5.65M
Total Non-current Assets321.61M164.63M67.33M42.56M14.14M
Total Assets1.12B710.6M398.03M303.85M280.41M
Account Payables9.75M12.98M9.85M11.56M10.77M
Short-term Debt000020.5M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities15.74M9.58M5.55M5.55M22.27M
Total Current Liabilities85.2M68.2M51.27M61.4M53.54M
Long-term Debt000063.16M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities226.75M162.93M117.26M99.02M8.63M
Total Non-current Liabilities352.48M275.76M215.78M181.71M137.04M
Total Liabilities437.68M343.96M267.05M243.11M190.57M
Common Stock19K19K19K19K2K
Retained Earnings(2.83B)(3.2B)(3.48B)(3.6B)(3.76B)
Accumulated OCI(4.16M)(6.91M)80K61K17K
Other Stockholders Equity00000
Minority Interest00000
Total Equity679.51M366.64M130.99M60.74M89.83M
Total Debt143.18M131.5M117.78M102.56M148.91M
Net Debt117.96M43.27M82.5M58.31M133.79M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$39.1M
Short-term Investments$645.2M
Receivables$4.8M
Other Current$50.3M
Total Current Assets$739.4M
PP&E (Net)$4.3M
Long-term Investments$340.5M
Other Non-current$11.0M
Total Non-current Assets$355.7M
Total Assets$1.1B

Analysis

Selected assets total $1.1B for Latest. The largest visible component is Short-term Investments at $645.2M, about 58.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 13, 2026
8-KCurrent reportNov 13, 2026
8-KCurrent reportNov 12, 2026
SC 13GSC 13G filingNov 10, 2026
S-8S-8 filingOct 20, 2026

How much cash does NKTR have?

Nektar Therapeutics (NKTR) reported $15.12M in cash and equivalents in fiscal 2025.

How much debt does NKTR carry?

Nektar Therapeutics (NKTR) reported $148.91M of total debt, with net debt of $133.79M.